You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 11,376,237


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,376,237 protect, and when does it expire?

Patent 11,376,237 protects VABOMERE and is included in one NDA.

This patent has fifteen patent family members in fourteen countries.

Summary for Patent: 11,376,237
Title:Methods of treating bacterial infections
Abstract: Methods of treating bacterial infection in immunocompromised subjects and subjects with one or more underlying malignancies include administering a combination of meropenem and vaborbactam to the subject. Suitable subjects to be treated can include a subject with a history of ongoing leukemia or lymphoma, a subject that has had an organ transplant, stem cell transplant, bone marrow transplant, or splenectomy, a subject receiving immunosuppressive medications, a subject receiving bone marrow ablative chemotherapy, a subject with neutropenia and subject suffering from or having suffered from a malignancy.
Inventor(s): Alexander; Elizabeth (Maplewood, NJ), Loutit; Jeffrey S. (Los Altos, CA), Dudley; Michael N. (San Diego, CA)
Assignee: MELINTA SUBSIDIARY CORP. (Morristown, NJ)
Application Number:16/753,288
Patent Claim Types:
see list of patent claims
Use; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with the exclusive rights to their inventions. The United States Patent and Trademark Office (USPTO) plays a crucial role in granting these patents, and understanding the scope and claims of these patents is essential for navigating the complex landscape of intellectual property.

The Role of the USPTO

The USPTO is the agency responsible for granting U.S. patents and registering trademarks. It ensures that patents are granted to inventions that meet the criteria of novelty, non-obviousness, and usefulness[2].

Patent Activity and Trends

In recent years, the USPTO has seen significant activity in patent grants. For instance, in 2018, the USPTO awarded 309,000 utility patents, with nearly equal distribution between foreign and domestic inventors. Businesses received the majority of these patents, with 85% going to corporate entities, while individuals, the academic sector, and the government sector received smaller shares[1].

Industry Affiliation and R&D

The computer and electronics manufacturing industry has been particularly active in patenting, receiving almost 30,000 patents in 2017. This industry also reported the highest level of domestic R&D performance, with approximately $79 billion spent in 2017. High R&D industries generally have high rates of patenting, reflecting their innovative activities[1].

Patent Technology Areas and Trends

Patents are classified into various technology areas, which help in analyzing trends in patenting focus over time. The USPTO uses the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields. In 2018, electrical and mechanical engineering patents made up about 60% of all USPTO patents, with electrical engineering patents more than doubling between 2000 and 2018. This increase is largely driven by advancements in information and communication technologies (ICT), particularly in computer technology and digital communication[1].

Patent Claims and Scope

The Patent Claims Research Dataset by the USPTO provides detailed information on claims from U.S. patents granted between 1976 and 2014. This dataset includes individually-parsed claims, claim-level statistics, and document-level statistics, offering insights into the scope of patents. For example, the dataset helps in measuring patent scope by analyzing the dependency relationship between claims and the breadth of the claims themselves[3].

Example: Patent 11,376,237

To illustrate the analysis of a specific patent, let's consider a hypothetical example (since the specific details of Patent 11,376,237 are not provided in the sources). When analyzing a patent, one would typically look at the following:

Claims

  • The claims section of a patent defines the scope of the invention. It outlines what the inventor considers to be the novel and non-obvious aspects of the invention.
  • Each claim is carefully crafted to ensure it is specific enough to be enforceable but broad enough to cover the invention's essence.

Description and Drawings

  • The detailed description and drawings provide context to the claims, explaining how the invention works and its various embodiments.
  • This section is crucial for understanding the invention's functionality and its potential applications.

Background and Summary

  • The background section often discusses the prior art and the problems the invention aims to solve.
  • The summary section provides a brief overview of the invention, highlighting its key features and advantages.

Analyzing Patent Scope

When analyzing the scope of a patent like 11,376,237, one would consider the following:

Claim Construction

  • How are the claims constructed? Are they broad or narrow?
  • What are the key elements of each claim, and how do they relate to the invention as a whole?

Prior Art

  • How does the patent differentiate itself from prior art?
  • What novel features or improvements does the patent introduce?

Infringement Analysis

  • How might the claims be interpreted in the context of potential infringement?
  • Are there any limitations or exceptions that could affect the patent's enforceability?

Specialized Patent Classification

Certain fields, like nanotechnology, require specialized classification systems. For instance, the USPTO created a cross-reference-art collection class (977) for nanotechnology patents. Similar efforts have been made by the European Patent Office (EPO) and the Japan Patent Office (JPO) to categorize and track nanotechnology-related patents[4].

The Need for a Small Claims Patent Court

There has been ongoing discussion about the need for a small claims patent court to handle disputes involving smaller inventors and companies. The Administrative Conference of the United States (ACUS) conducted a study on this topic, engaging with various stakeholders to explore the feasibility and potential structure of such a court. This initiative aims to make the patent litigation process more accessible and cost-effective for smaller entities[5].

Key Takeaways

  • Patent Activity: The USPTO grants a significant number of patents annually, with a strong focus on electrical and mechanical engineering.
  • Industry Trends: High R&D industries, such as computer and electronics manufacturing, are highly active in patenting.
  • Patent Scope: Analyzing patent claims and descriptions is crucial for understanding the invention's scope and potential applications.
  • Specialized Classification: Certain fields like nanotechnology require specialized classification systems.
  • Small Claims Court: There is a growing need for a small claims patent court to support smaller inventors and companies.

FAQs

What is the primary role of the USPTO?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that inventions meet the criteria of novelty, non-obviousness, and usefulness.

How are patents classified by the USPTO?

The USPTO uses the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields to categorize patents.

What is the significance of the Patent Claims Research Dataset?

The dataset provides detailed information on claims from U.S. patents, helping in the analysis of patent scope and the dependency relationship between claims.

Why is there a need for a small claims patent court?

A small claims patent court would make patent litigation more accessible and cost-effective for smaller inventors and companies, addressing the current barriers to justice in patent disputes.

How do specialized classification systems help in tracking patents?

Specialized classification systems, such as those for nanotechnology, help in categorizing and tracking patents in specific fields, providing a comprehensive view of innovation trends.

Sources

  1. NCSES, "Invention: U.S. and Comparative Global Trends," January 15, 2020.
  2. USA.gov, "U.S. Patent and Trademark Office (USPTO)," accessed December 20, 2024.
  3. USPTO, "Patent Claims Research Dataset," August 28, 2017.
  4. OECD, "Capturing Nanotechnology's Current State of Development via Patent Analysis," May 23, 2007.
  5. ACUS, "U.S. Patent Small Claims Court," accessed December 20, 2024.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,376,237

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Rempex VABOMERE meropenem; vaborbactam POWDER;INTRAVENOUS 209776-001 Aug 29, 2017 RX Yes Yes 11,376,237 ⤷  Subscribe TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS (CUTI) INCLUDING PYELONEPHRITIS CAUSED BY THE FOLLOWING SUSCEPTIBLE MICROORGANISMS: ESCHERICHIA COLI,KLEBSIELLA PNEUMONIA,ENTEROBACTER CLOACAE SPECIES COMPLEX WITH MEROPENEM & VABORBACTAM AS SPECIFIED ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 11,376,237

PCT Information
PCT FiledOctober 01, 2018PCT Application Number:PCT/US2018/053772
PCT Publication Date:April 11, 2019PCT Publication Number: WO2019/070591

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.